Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Wallin Pharma AB
AB
Active
Org 5565104089
Mårdgatan 3, 233 42
Svedala
Other financial service activities, except insurance and pension funding n.e.c.
·
NACE 6499
Est. 1995 · 31 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Other financial service activities, except insurance and pension funding n.e.c.
/
Wallin Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
0
0
0
0
0
Depreciation & amort.
−0
−0
—
−0
−0
EBIT
0
0
0
0
0
Net financials
68
60
14
−36
7
Profit before tax
68
60
14
36
7
Tax
−0
−0
—
−0
−0
Net profit
68
60
14
36
7
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
304
286
302
288
252
Equity
304
286
302
288
252
Long-term debt
0
0
—
0
0
Short-term debt
0
0
—
0
0
Total debt
—
—
—
—
—
Financial ratios
5-year trend
EBITDA margin
0,0 %
This company
15,8 %
Market median
This company
Market median
100% below market
2020
2024
Equity ratio
100,0 %
This company
38,2 %
Market median
This company
Market median
162% above market
2020
2024
Return on equity
22,4 %
This company
18,4 %
Market median
This company
Market median
22% above market
2020
2024
Net profit margin
>999 %
This company
8,1 %
Market median
This company
Market median
>999% above market
2020
2024
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2020
2024
Debt / equity
0,00×
This company
0,62×
Market median
This company
Market median
100% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Wallin Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
